Literature DB >> 33967415

Surgical management of empyema thoracis - experience of a decade in a tertiary care centre in India.

Santhosh Regini Benjamin1, Rijoy Kolakkada Panakkada1, Shalom Sylvester Andugala1, Birla Roy Gnanamuthu1, Vinay Murahari Rao1, Deepak Narayanan1, Aamir Mohammad1, Mallampati Sameer1.   

Abstract

INTRODUCTION AND
PURPOSE: Empyema thoracis (ET) is defined as the accumulation of pus in the pleural cavity. Early stages of ET are treated medically and the late stages surgically. Decortication, thoracoplasty, window procedure (Eloesser flap procedure) and rib resections are the open surgical procedures executed. There are no strict guidelines available in developing nations to guide surgical decision-making, as to which procedure is to be followed.
METHODS: Details of all adult patients treated surgically for ET, between the years 2009 and 2019, and maintained in a live database in our institute, were retrieved and analysed. Medically managed patients were excluded.
RESULTS: There were 437 patients in the study. The average age was 38 years. There was right side preponderance with a male:female ratio of 5:1. Tuberculosis was the commonest aetiology identified in 248 (57%) patients and diabetes was the commonest co-morbidity present in 97 (22%) patients. There was a higher incidence of a window procedure (WP) in tubercular patients 145 (59%). Only 26 (14%) of the non-tubercular patients underwent a WP. Post-operative complications were persistent air leak in 12 (6%) patients and premature closure of a window in 7 (4%) patients. There were 4 (0.9%) post-operative mortalities.
CONCLUSION: Surgical management of late stages of ET provides good results with minimal morbidity and mortality. In developing nations like India, the high incidence of tuberculosis and late presentations make the surgical management difficult and the strategies different from those in developed nations. No clear guidelines exist for the surgical management of ET in developing nations. There is a need for a consensus on the surgical management of empyema in such countries. © Indian Association of Cardiovascular-Thoracic Surgeons 2021.

Entities:  

Keywords:  Decortication; Empyema; Rib resection; Thoracoplasty; Tuberculosis; Window procedure

Year:  2021        PMID: 33967415      PMCID: PMC8079569          DOI: 10.1007/s12055-020-01085-x

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  16 in total

1.  Clinical characteristics and outcomes of empyema thoracis in 117 patients: a comparative analysis of tuberculous vs. non-tuberculous aetiologies.

Authors:  P Malhotra; A N Aggarwal; R Agarwal; P Ray; D Gupta; S K Jindal
Journal:  Respir Med       Date:  2006-10-12       Impact factor: 3.415

Review 2.  Complications of pulmonary resection.

Authors:  M M Kirsh; H Rotman; D M Behrendt; M B Orringer; H Sloan
Journal:  Ann Thorac Surg       Date:  1975-08       Impact factor: 4.330

Review 3.  Persistent air leaks: a review with an emphasis on bronchoscopic management.

Authors:  Donald R Lazarus; Roberto F Casal
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis.

Authors:  C Tueller; P N Chhajed; C Buitrago-Tellez; R Frei; M Frey; M Tamm
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

5.  EACTS expert consensus statement for surgical management of pleural empyema.

Authors:  Marco Scarci; Udo Abah; Piergiorgio Solli; Aravinda Page; David Waller; Paul van Schil; Franca Melfi; Ralph A Schmid; Kalliopi Athanassiadi; Miguel Sousa Uva; Giuseppe Cardillo
Journal:  Eur J Cardiothorac Surg       Date:  2015-08-07       Impact factor: 4.191

6.  Adult thoracic empyema: A comparative analysis of tuberculous and nontuberculous etiology in 75 patients.

Authors:  Somenath Kundu; Subhra Mitra; Subhasis Mukherjee; Soumya Das
Journal:  Lung India       Date:  2010-10

7.  Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre.

Authors:  Daniel J B Marks; Marie D Fisk; Chieh Y Koo; Menelaos Pavlou; Lorraine Peck; Simon F Lee; David Lawrence; M Bruce Macrae; A Peter R Wilson; Jeremy S Brown; Robert F Miller; Alimuddin I Zumla
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

8.  Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis.

Authors:  Hyeri Seok; Ji Hoon Jeon; Kyung Ho Oh; Hee Kyoung Choi; Won Suk Choi; Young Hen Lee; Hyung Suk Seo; Soon Young Kwon; Dae Won Park
Journal:  BMC Infect Dis       Date:  2019-10-21       Impact factor: 3.090

9.  Thoracoscopic management of empyema thoracis.

Authors:  Michael A Wait; Daniel L Beckles; Michelle Paul; Margaret Hotze; Michael J Dimaio
Journal:  J Minim Access Surg       Date:  2007-10       Impact factor: 1.407

10.  Open thoracotomy and decortication for chronic empyema.

Authors:  Rafael Andrade-Alegre; Juan D Garisto; Salomón Zebede
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.